Related Experiment Video
Updated: Feb 9, 2026

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy
1Department of Pathology, Laboratory of Morphology and Molecular Pathology, University Hospitals of Leuven, Minderbroederstraat 12, B-3000 Leuven, Belgium. tania.roskams@uz.kuleuven.ac.be
Abstract:
A better understanding of signaling pathways in HCC pathogenesis has led to targeted therapies against HCC. Identification of liver cancer stem cell markers and their related pathways is one of the most important goals of liver cancer research. New therapies should ideally target cancer stem cells and not normal stem/progenitor cells, because the latter are very important in regeneration and repair. Individualized HCC therapy will require better definition of patient subgroups that benefit most or should be protected from therapy failure and unwanted side effects. Tumor tissue acquisition should be mandatory, reversing the practice that was established years ago when targeted HCC therapy was but a pipe dream.
Insights
Understanding liver cancer signaling pathways aids targeted therapies. Research focuses on liver cancer stem cell markers to develop new treatments that spare normal cells, enabling personalized medicine.
Area of Science:
- Hepatocellular carcinoma (HCC) research
- Cancer stem cell biology
- Targeted cancer therapy
Background:
- Advances in understanding HCC pathogenesis have enabled targeted therapies.
- Liver cancer stem cells are crucial targets for novel therapeutic strategies.
- Distinguishing between cancer stem cells and normal stem/progenitor cells is vital for effective treatment design.
Purpose of the Study:
- To highlight the importance of identifying liver cancer stem cell markers and their associated pathways.
- To emphasize the need for therapies that selectively target cancer stem cells.
- To underscore the necessity of defining patient subgroups for personalized HCC treatment.
Main Methods:
- Review of current understanding of HCC signaling pathways.
- Analysis of liver cancer stem cell marker identification strategies.
- Discussion of principles for developing targeted therapies against HCC.
Main Results:
- Targeted therapies are increasingly effective due to better pathway comprehension.
- Identification of specific liver cancer stem cell markers is a key research objective.
- Personalized medicine approaches require precise patient stratification.
Conclusions:
- Targeting liver cancer stem cells offers a promising therapeutic avenue.
- Future HCC therapies must differentiate between malignant and normal stem cells.
- Mandatory tumor tissue acquisition is essential for advancing personalized HCC treatment.
More Related Videos
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Impact of Groups on Groups
Diencephalon: Anatomical Regions
Cerebrum: Anatomical Overview II
Anatomical Positions
The body is upright, facing forward, and standing erect.
The feet are parallel and flat on the floor.
The arms are hanging by the...
Anatomical Terminology
Anatomical Movements
Here are some common anatomical movements:
Flexion and extension motions are in the sagittal (anterior–posterior) plane of motion. These movements take place at the shoulder, hip, elbow, knee, wrist,...